Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

HAT1 Citations (4)

Originally described in: Structural Genomics Consortium Clones
Unpublished

Articles Citing HAT1

Articles
Bisubstrate inhibitors to target histone acetyltransferase 1. Ngo L, Brown T, Zheng YG. Chem Biol Drug Des. 2019 May;93(5):865-873. doi: 10.1111/cbdd.13476. Epub 2019 Jan 30. PubMed
Identification of lysine isobutyrylation as a new histone modification mark. Zhu Z, Han Z, Halabelian L, Yang X, Ding J, Zhang N, Ngo L, Song J, Zeng H, He M, Zhao Y, Arrowsmith CH, Luo M, Bartlett MG, Zheng YG. Nucleic Acids Res. 2021 Jan 11;49(1):177-189. doi: 10.1093/nar/gkaa1176. PubMed
Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2. Delaney K, Tan M, Zhu Z, Gao J, Dai L, Kim S, Ding J, He M, Halabelian L, Yang L, Nagarajan P, Parthun MR, Lee S, Khochbin S, Zheng YG, Zhao Y. Cell Discov. 2021 Dec 28;7(1):122. doi: 10.1038/s41421-021-00344-4. PubMed
Chemoproteomic Profiling of Protein Substrates of a Major Lysine Acetyltransferase in the Native Cellular Context. Song J, Ngo L, Bell K, Zheng YG. ACS Chem Biol. 2022 May 20;17(5):1092-1102. doi: 10.1021/acschembio.1c00935. Epub 2022 Apr 13. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.